Ten Questions Screen Helps ID Disability in HIV+ Children

Share this content:
Ten Questions Screen Helps ID Disability in HIV+ Children
Ten Questions Screen Helps ID Disability in HIV+ Children

THURSDAY, July 19, 2018 (HealthDay News) -- The Ten Questions (TQ) screen is an effective way to screen HIV-positive children for neurodevelopmental problems in resource-poor areas, according to a study published online July 3 in PLOS ONE.

Justin Knox, M.P.H., from Columbia University in New York City, and colleagues assess the ability of the TQ screen to identify developmental disability among HIV-positive and HIV-negative children living in South Africa. Participants included 1,330 4-to-6-year-old children and 1,231 of their caregivers.

The researchers found that there was a high prevalence of disability in the sample. HIV-positive children were more likely to screen positive on at least one TQ item (59.3 versus 42.8 percent; P = 0.01), be delayed in sitting, standing or walking (odds ratio [OR], 3.89) and have difficulty walking or weakness in the arms or legs (OR, 2.7), compared to HIV-negative children. HIV-positive children were more likely to be diagnosed, through a doctor's assessment, with gross motor disability (OR, 3.5) and hearing disability (OR, 2.5). HIV-positive children were also more likely to have cognitive delay (OR, 2.2) and language delay (OR, 4.3), based on independent psychological assessment. The sensitivity and specificity of the TQ for serious disability among HIV-positive children was 100 and 51.2 percent, respectively, and 90.2 and 63.9 percent, respectively, among HIV-negative children.

"In this first report of the use of the TQ screen in the isiZulu language, it was found to have high sensitivity for detecting serious developmental disabilities in children, especially HIV-positive children," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »